Investor insights
Sectors invested in
Funding rounds participated in
$51M sweet spot round size
Most of their 11 investments are in rounds between $9.4M and $55M
Investor type
Basic info
Industry
Sectors
Date founded
2017
Investments made
Switch Therapeutics raised $52M on March 14, 2023
Investors: Digitalis Ventures, Freeflow Ventures, Dolby Family Ventures, Global Brain Corporation, Insight Partners, Upfront Ventures and UCB Ventures
ProteoDesign raised $57M on February 15, 2022
Investors: Gilde Healthcare, Ysios Capital, Asabys Partners and UCB Ventures
Neurona Therapeutics raised $42M on June 22, 2021
Investors: Sphera Fund, Ironfire Capital LLC, The Column Group and UCB Ventures
StrideBio, Inc raised $82M on March 16, 2021
Investors: Octagon Capital Advisors, Northpond Ventures, UF Innovate | Ventures, Novo Holdings, Takeda UK Limited, CaaS Capital Management, Pontifax Venture Capital, Sarepta Therapeutics and UCB Ventures
Locana, Inc. raised $100M on December 14, 2020
Investors: Acuta Capital, Lightstone Ventures, The Invus Group, SVB Securities, GV, Vida Ventures, LLC, ARCH Venture Partners, Temasek, RA Capital Management, L.P. and UCB Ventures
Walden Biosciences raised $51M on October 6, 2020
Investors: ARCH Venture Partners and UCB Ventures
Syndesi Therapeutics raised $7M on September 28, 2020
Investors: SRIW, -, Vives Louvain Technology Fund, Novo Holdings, V-Bio Ventures and UCB Ventures
ExeVir raised $49M on July 28, 2020
Investors: SRIW, Vives Louvain Technology Fund, -, FundPlus, VIB, V-Bio Ventures and UCB Ventures
MyHealthTeams raised $9.4M on August 15, 2019
Investors: HealthTech Capital, Sand Hill Angels, Qiming Venture Partners, CVS Health, The Westly Group, Adams Street Partners, 500 Startups and UCB Ventures
Locana, Inc. raised $55M on May 22, 2019
Investors: GV, Lightstone Ventures, Temasek, ARCH Venture Partners and UCB Ventures